Cypress Bioscience Announces the Closing of the Partnership With Fresenius AG; Fresenius Invests in Cypress Common Stock and Warrants.
Business Wire › March 29, 1999
Linked as:
Extract
Cypress Bioscience Announces the Closing of the Partnership With Fresenius AG; Fresenius Invests in Cypress Common Stock and Warrants.
SAN DIEGO--(BW HealthWire)--March 29, 1999--
Prosorba(R) Column Rheumatoid Arthritis Launch Planned for Early April Cypress Bioscience, Inc. (Nasdaq:CYPB) announced today that all contingencies have been met and it has entered into a partnership agre...See the full content of this document
Sponsored links
